Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment

Open Access

Peer-reviewed

Research Article

Smita Nayak ,

* E-mail: nayaks@upmc.edu

Affiliation Section of Decision Sciences and Clinical Systems Modeling, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
⨯
Mark S. Roberts,

Affiliations Section of Decision Sciences and Clinical Systems Modeling, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America
⨯
Susan L. Greenspan

Affiliation Division of Endocrinology and Metabolism and Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
⨯

Reader Comments (0)

Osteoporosis
Is the Subject Area "Osteoporosis" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Nursing homes
Is the Subject Area "Nursing homes" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Hip
Is the Subject Area "Hip" applicable to this article?

Thanks for your feedback.
Spine
Is the Subject Area "Spine" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.